Phenylketonuria (PKU)

Print

Bio-Rad’s Microplate Neonatal Phenylketonuria (PKU) Screen quantitatively determines phenylalanine levels in neonatal dried blood spot samples as a screen for phenylketonuria (PKU). Bio-Rad’s PKU screen is easily automated and can provide results in less than two hours. It eliminates the antibiotic interference and subjectivity inherent in traditional bacterial-inhibition assays.

Most PKU cases are the result of a deficiency in the enzyme phenylalanine hydroxylase. Early detection and treatment of PKU is critical for the prevention of mental retardation. Bio-Rad is recognized as a worldwide market leader in neonatal PKU assays.

x

Account price failed to display. Please try reloading the page. Reload Page

If you are placing an order, you may proceed with your order; the account price will be applied if it is lower than the
list price. If the problem persists, please call customer service at   or send an
email to 

Quantase™ Neonatal PKU Screen (S&S 903 paper) (500 tests)
Quantase™ Neonatal Phenylalanine Screening (S&S 903 paper)

532-5052
Quantitative assay to determine phenylalanine levels in neonatal dried blood spot samples, as a screen for phenylketonuria (PKU), (500 tests)

List Price:
 
Inquire
Loading
Your Price:
 

Communication error

Reload Page

Quantity:   Add to Quote
Add to Hot List  
Quantase™ Neonatal Phenylalanine Screening
Quantase™ Neonatal Phenylalanine Screening

532-5053
Quantitative assay to determine phenylalanine levels in neonatal dried blood spot samples, as a screen for phenylketonuria (PKU), (2000 tests)

List Price:
 
Inquire
Loading
Your Price:
 

Communication error

Reload Page

Quantity:   Add to Quote
Add to Hot List